Neoadjuvant Capecitabine and Oxaliplatin Before Concurrent Capecitabine and Radiation in Locally Advanced Rectal Cancers: Experience of a Cancer Hospital in Pakistan.
Muhammad Atif ManshaAsmara WaheedTabinda SadafAsma RashidNabia IrfanSamreen Javed ChaudryPublished in: JCO global oncology (2021)
Neoadjuvant chemotherapy with CAPOX before CAPRT and planned total mesorectal excision surgery result in good tumor regression and substantial pathologic complete response rates with acceptable toxicity. With growing interest in organ preservation in rectal cancer, the strategy of completing all chemotherapy and chemoradiotherapy before planned surgery offers a favorable paradigm. However, further randomized clinical trials are needed to support this evidence.
Keyphrases
- locally advanced
- rectal cancer
- neoadjuvant chemotherapy
- phase ii study
- minimally invasive
- coronary artery bypass
- sentinel lymph node
- surgical site infection
- papillary thyroid
- squamous cell carcinoma
- healthcare
- oxidative stress
- radiation therapy
- percutaneous coronary intervention
- emergency department
- clinical trial
- randomized controlled trial
- early stage
- childhood cancer
- radiation induced
- young adults